NCT03319459 FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03318562 A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC Status TERMINATED Phase PHASE2
NCT03313596 Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC Status UNKNOWN Phase PHASE3
NCT03311152 Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis Status COMPLETED Phase NA
NCT03307408 Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease Status COMPLETED Phase N/A
NCT03303469 Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging Status TERMINATED Phase PHASE2
NCT03302403 Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors Status UNKNOWN Phase NA
NCT03300401 Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization Status WITHDRAWN Phase NA
NCT03298451 Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03295006 A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC Status COMPLETED Phase N/A
NCT03292991 REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN) Status UNKNOWN Phase N/A
NCT03285867 Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma Status UNKNOWN Phase N/A
NCT03273608 Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients Status UNKNOWN Phase N/A
NCT03268499 Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma Status COMPLETED Phase NA
NCT03267641 Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma Status COMPLETED Phase N/A